Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takuya Harada

Showing results (61-70 of 62) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 62 results.
American Journal of Hematology|October 19, 2022
Predictors of impaired antibody response after SARS-CoV-2 mRNA vaccination in hematopoietic cell transplant recipients: A Japanese multicenter observational studyYasuo Mori, Naoyuki Uchida, Takuya Harada, et al.
International Journal of Cancer|January 12, 2018
WT1 peptide-based immunotherapy for advanced thymic epithelial malignanciesYusuke Oji, Masayoshi Inoue, Yoshito Takeda, et al.
Pageof 7

Showing results (61-70 of 62) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 62 results.
American Journal of Hematology|October 19, 2022
Predictors of impaired antibody response after SARS-CoV-2 mRNA vaccination in hematopoietic cell transplant recipients: A Japanese multicenter observational studyYasuo Mori, Naoyuki Uchida, Takuya Harada, et al.
International Journal of Cancer|January 12, 2018
WT1 peptide-based immunotherapy for advanced thymic epithelial malignanciesYusuke Oji, Masayoshi Inoue, Yoshito Takeda, et al.
Pageof 7